Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]. (2023)

First Author: Liu X

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2023.03.025

PubMed Identifier: 37055303

Publication URI: http://europepmc.org/abstract/MED/37055303

Type: Journal Article/Review

Volume: 86

Parent Publication: The Journal of infection

Issue: 5

ISSN: 0163-4453